|
Product class:
|
Authorized package
|
|
Medicinal product class:
|
For human use
|
|
Package code:
|
1113455
|
|
Name of medicinal product:
|
NEO-ANGIN SUHKRUVABA
|
|
Active substances:
|
|
|
ATC code:
|
R02AA95
|
|
Dosage form:
|
lozenge
|
|
Route of administration:
|
oromucosal use
|
|
Strengh:
|
0,6mg+1,2mg+5,72mg
|
|
Amount in package:
|
24TK
|
|
Legal status for supply*:
|
Not subject to medicinal prescription
|
|
Class of active substance:
|
|
|
Additional information:
|
|
|
Indication:
|
|
|
Safety features:
|
No
|
|
Summary of product characteristics (SPC):
|
 (last updated May 31, 2021)
|
|
Package information leaflet (PIL):
|
EST (last updated May 31, 2021)
|
|
Translation of package information leaflet into Russian:
|
RUS (last updated May 31, 2021)
|
|
Translation of package information leaflet into English:
|
ENG (last updated May 31, 2021)
|
|
Labelling:
|
(last updated May 31, 2021)
|
|
Last imported to Estonia:
|
September 12, 2023
|
|
Marketing authorization holder:
|
Divapharma GmbH
|
|
Marketing authorization number:
|
496005
|
|
Marketing authorization issued on:
|
September 30, 2005
|
|
Marketing authorization expires on:
|
Unlimited
|
|
Marketing authorization procedure type:
|
National
|
|
Reference price:
|
|
|
Under reference price:
|
|
|
Reference price of daily dose:
|
|
Entry/Changing date:
May 31, 2021
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere